Detail page

Knowledge Web

Person

Anna Nikoghosyan (1974-)

Ärztin

Name	Anna Nikoghosyan
Time	1974- (Date of birth and death)
Place	Deutschland
Gender	weiblich
Academic degree	Dr. med.
Profession	Ärztin (characteristic profession) Wissenschaftliche Mitarbeiterin
Variant	Anna V. Nikoghosyan A. V. Nikoghosyan
Related	Klinik für RadioOnkologie und Strahlentherapie (Heidelberg) (7/2003-) Radiologische Klinik (Heidelberg) Deutsches Krebsforschungszentrum
Record type	Person
GND-Identifier	129613355
Record ID	129613355
Involved in show all Clinical Phase I/II trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma : interim analysis A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma Evaluation of the therapeutical potential of heavy ion therapy in patients with locally advanced prostate cancer

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Anna Nikoghosyan (1974-)

Clinical Phase I/II trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis

Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma : interim analysis

A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma

IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study

Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial

Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma

Evaluation of the therapeutical potential of heavy ion therapy in patients with locally advanced prostate cancer